CRIMINAL LAWAND PROCEDURE
311
ignates as being the principal compound com-
monly used or produced primarily for use, and
which is an immediate chemical intermediate
used or likely to be used in the manufacture of a
controlled substance, the control of which is nec-
essary to prevent, curtail, or limit manufacture.
35-48-1-18. “Manufacture” defined.
“Manufacture” means the following:
(1) For offenses not involving marijuana,
hashish, or hash oil:
(A) the production, preparation, prop-
agation, compounding, conversion, or
processing of a controlled substance,
either directly or indirectly by extrac-
tion from substances of natural origin,
independently by means of chemical
synthesis, or by a combination of
extraction and chemical synthesis, and
includes any packaging or repackaging
of the substance or labeling or rela-
beling of its container. It does not
include the preparation, compounding,
packaging, or labeling of a controlled
substance:
(i) by a practitioner as incident to
administering or dispensing of a
controlled substance in the course
of a professional practice; or
(ii) by a practitioner, or by the
practitioner’s authorized agent
under the practitioner’s supervi-
sion, for the purpose of, or as an
incident to, research, teaching, or
chemical analysis and not for sale;
or
(B) the organizing or supervising or
an activity described in clause (A).
(2) For offenses involving marijuana,
hashish, or hash oil:
(A) the preparation, compounding,
conversion, or processing of marijuana,
hashish, or hash oil, either directly or
indirectly by extraction from sub-
stances of natural origin, independ-
ently by means of chemical synthesis,
or by a combination of extraction and
chemical synthesis, and includes any
packaging or repackaging of the mar-
ijuana, hashish, or hash oil, or labeling
or relabeling of its container. It does
not include planting, growing, culti-
vating, or harvesting a plant, or the
preparation, compounding, packaging,
or labeling of marijuana, hashish, or
hash oil:
(i) by a practitioner as an incident
to lawfully administering or dis-
pensing of marijuana, hashish, or
hash oil in the course of a profes-
sional practice; or
(ii) by a practitioner, or by the
practitioner’s agent under the prac-
titioner’s supervision, for the pur-
pose of, or as an incident to,
research, teaching, or chemical
analysis and not for sale; or
(B) the organizing or supervising of
an activity described in clause (A).
35-48-1-19. “Marijuana” defined.
(a) “Marijuana” means any part of the plant
genus Cannabis whether growing or not; the seeds
thereof; the resin extracted from any part of the
plant, including hashish and hash oil; any com-
pound, manufacture, salt, derivative, mixture, or
preparation of the plant, its seeds or resin.
(b) The term does not include:
(1) the mature stalks of the plant;
(2) fiber produced from the stalks;
(3) oil or cake made from the seeds of the
plant;
(4) any other compound, manufacture, salt,
derivative, mixture, or preparation of the
mature stalks (except the resin extracted
therefrom);
(5) the sterilized seed of the plant which is
incapable of germination; or
(6) industrial hemp (as defined by IC 15-
15-13-6).
35-48-1-20. “Narcotic drug” defined.
“Narcotic drug” means any of the following,
whether produced directly or indirectly by extrac-
tion from substances of vegetable origin, inde-
pendently by means of chemical synthesis, or by
a combination of extraction and chemical syn-
thesis:
(1) Opium and opiate, and any salt, com-
